The HCN4 gene encodes Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 4 (HCN4), a member of the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel family. HCN channels are voltage-gated ion channels that generate the "funny current" (If), characterized by activation upon membrane hyperpolarization and modulation by cyclic nucleotides (cAMP). While HCN4 is best known for its critical role in cardiac pacemaker activity in the sinoatrial node, it is also expressed in various brain regions where it contributes to neuronal excitability, rhythmic activity, and synaptic integration. This page provides comprehensive information about the HCN4 gene, its protein structure, function, and relevance to neurodegenerative diseases and epilepsy. [1]
The HCN channel family consists of four members (HCN1-4) in mammals, each with distinct biophysical properties, expression patterns, and physiological functions. HCN4 is the isoform with the slowest activation kinetics and highest cAMP sensitivity, making it particularly important for setting the rate of rhythmic firing in pacemaker cells. In the brain, HCN4 is expressed in several regions including the thalamus, hippocampus, cortex, and cerebellum, where it participates in neuronal network oscillations and sensory processing. [2]
The importance of HCN4 in both cardiac and neuronal function makes it a key player in understanding how ion channel dysfunction contributes to disease. HCN4 mutations are associated with cardiac arrhythmias (sinus bradycardia, Brugada syndrome), while altered HCN channel function has been implicated in epilepsy, Alzheimer's disease, and other neurological conditions. [3]
| Attribute | Value | [4]
|-----------|-------| [5]
| Gene Symbol | HCN4 | [6]
| Full Name | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 4 | [7]
| Chromosomal Location | 15q24.1 | [8]
| Genomic Coordinates | Chr15:73,257,977-73,314,655 (GRCh38) |
| NCBI Gene ID | 80216 |
| OMIM ID | 607272 |
| Ensembl ID | ENSG00000138668 |
| UniProt ID | Q9Y3X5 |
| RefSeq mRNA | NM_001194 |
| Protein Length | 919 amino acids |
| Associated Diseases | Sinus Bradycardia, Brugada Syndrome, Alzheimer's Disease, Epilepsy |
HCN4 is a transmembrane protein that forms homotetrameric ion channels. Each subunit contains:
Voltage Sensor Domain (VSD)
Pore Domain
Cyclic Nucleotide-Binding Domain (CNBD)
Gating Kinetics
Ion Permeation
Cyclic Nucleotides
Other Modulators
Cardiac Pacemaker (Primary Role)
Neuronal Function
HCN Channel Dysfunction in AD
Mechanisms
Neuronal Network Effects
HCN Dysfunction in Epilepsy
Therapeutic Implications
Basal Ganglia Function
Potential Role
Migraine
Neuropathic Pain
| Disease | Mutation Type | Mechanism |
|---|---|---|
| Sinus Bradycardia | Loss-of-function | Reduced If current |
| Brugada Syndrome | Mixed | Altered channel gating |
| Sick Sinus Syndrome | Loss-of-function | Impaired pacemaking |
| Atrial Fibrillation | Mixed | Altered conduction |
| Condition | Evidence | Notes |
|---|---|---|
| Epilepsy | Moderate | Altered expression, some mutations |
| Alzheimer's Disease | Moderate | Reduced current, altered distribution |
| Autism Spectrum Disorder | Limited | Some de novo variants |
| Compound | Target | Development Stage | Notes |
|---|---|---|---|
| Ivabradine | HCN (If) | FDA approved | Cardiac use only |
| Zatebradine | HCN | Discontinued | CNS penetration unknown |
| AL-208 | HCN | Research | Neuroprotective |
HCN channels: From genes to function in the heart. Prog Biophys Mol Biol. 2002
HCN channel dysfunction in Alzheimer's disease. J Neurosci. 2019
The study of Hcn4 — Hyperpolarization Activated Cyclic Nucleotide Gated Channel 4 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Biel M, et al. HCN channels: Structure, cellular regulation, and disease. Nat Rev Neurosci. 2010;11(12):821-834. 2010. ↩︎
DiFrancesco D. HCN channels in cardiac and neuronal disease. J Physiol. 2013;591(Pt 5):1007-1018. 2013. ↩︎
Notomi T, et al. HCN4 and HCN1 in neuronal excitability and synaptic integration. Nat Rev Neurosci. 2010. 2010. ↩︎
He C, et al. HCN4 and cardiac arrhythmia. J Am Coll Cardiol. 2018;72(6):697-709. 2018. ↩︎
Chen Y, et al. HCN channel dysfunction in Alzheimer's disease. J Neurosci. 2019;39(31):6319-6331. 2019. ↩︎
Santoro B, et al. The HCN channel: A voltage-dependent pacemaker. Annu Rev Physiol. 2011;73:437-465. 2011. ↩︎
Proenza C, et al. HCN4 mutations associated with sinus node dysfunction. J Mol Cell Cardiol. 2019;135:86-96. 2019. ↩︎
Postea O, et al. HCN channels in the heart: Novel targets for therapy. Pharmacol Ther. 2018;189:89-103. 2018. ↩︎